Isigny Sainte-Mère Dairy Cooperative receives accreditation for infant formula milk powder testing laboratory The Isigny Sainte-Mère milk powder testing laboratory in France has recently received COFRAC ISO 17025 accreditation.
This standard, rarely obtained for an infant milk testing laboratory, is issued by the COFRAC (French Accreditation Committee), the only reference accreditation body in France. It validates and guarantees the cooperative’s high level of technical competence.
Every year, Isigny Sainte-Mère produces a large quantity of infant milk powders. Due to the sensitive nature of infants, the quality of these food products needs to be faultless, the cooperative said.
A New Research Published by DBMR on the Global
Wellness Supplements Market (COVID 19 Version) in various regions to produce more than 300+ page reports. This study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry and competitors’ challenges in gap analysis and new opportunities and may be trending in the Wellness Supplements Market..The study begins with the Wellness Supplements introduction, market dynamics in terms of drivers, restraints, challenges, and regulatory scenario by region and countries. Further, Wellness Supplements report involves market overview, key players profiling, key developments, suppliers of raw materials and dealers, among other information. It also consists of market size, sales, share, industry growth rate, and revenue.The Wellness Supplements market report helps in understanding customer inclination towards purchasing products.The report considers major regions Covers namely North America,
Dairy Dialog podcast 121: Tate & Lyle, Evolve Biosystems, Bridge Cheese
Dairy Dialog podcast 121: Tate & Lyle, Evolve Biosystems, Bridge Cheese This week we feature three interviews, with five guests. We have conversations with Timothy Brown, CEO of Evolve BioSystems and Pam Shepherd, managing director of Manna Tree; Jim Carr, PhD, director, sweeteners global ingredient technology and Abigail Storms, vice president of sweetener innovation at Tate & Lyle; and Michael Harte, managing director of Bridge Cheese. We also have our weekly look at the global dairy markets with Charlie Hyland at StoneX.
Evolve BioSystems announces investment from Cargill and Manna Tree for infant gut health probiotic
Data Bridge Market Research recently added “
Wellness Supplements Market by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries.
Wellness Supplements Market comprehensive coverage of underlying economic and technological factors under key trend analysis.
Wellness supplements market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 386.29 billion by 2027 growing at a CAGR of 6.45% in the above-mentioned forecast period. The growing awareness towards healthy lifestyles among the people globally will help in driving the growth of the wellness supplements
Evolve BioSystems announces investment from Cargill and Manna Tree for infant gut health probiotic US microbiome company Evolve BioSystems has announced that it completed a first close in a $55m Series D round of funding, led by Cargill, the global food, agricultural, financial and industrial products company and Manna Tree, an investment firm committed to improving human health.
The new capital will be used to help the company continue commercializing a next generation of probiotic capable of addressing a widespread deficiency in the infant gut microbiome. We are thrilled to announce our newest investors as we continue our quest to address this health crisis in newborns, said Timothy Brown, CEO of Evolve BioSystems.